These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23302740)

  • 21. Tick-Tattoo: DNA Vaccination Against
    Klouwens MJ; Trentelman JJA; Wagemakers A; Ersoz JI; Bins AD; Hovius JW
    Front Immunol; 2021; 12():615011. PubMed ID: 33717102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple antigen target approach using the Accuplex4 BioCD system to detect Borrelia burgdorferi antibodies in experimentally infected and vaccinated dogs.
    Moroff S; Woodruff C; Woodring T; Sokolchik I; Lappin MR
    J Vet Diagn Invest; 2015 Sep; 27(5):581-8. PubMed ID: 26289718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease.
    Coleman AS; Rossmann E; Yang X; Song H; Lamichhane CM; Iyer R; Schwartz I; Pal U
    Clin Vaccine Immunol; 2011 Mar; 18(3):406-13. PubMed ID: 21177911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies to OspC, OspF and C6 antigens as indicators for infection with Borrelia burgdorferi in horses.
    Wagner B; Goodman LB; Rollins A; Freer HS
    Equine Vet J; 2013 Sep; 45(5):533-7. PubMed ID: 23432019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of in vivo expressed Borrelia burgdorferi antigens for improved IgM serodiagnosis of early Lyme disease.
    Brandt KS; Ullmann AJ; Molins CR; Horiuchi K; Biggerstaff BJ; Gilmore RD
    Diagn Microbiol Infect Dis; 2019 Mar; 93(3):196-202. PubMed ID: 30344068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of recombinant antigens of Borrelia burgdorferi and Anaplasma phagocytophilum in enzyme-linked immunosorbent assays to detect antibodies in white-tailed deer.
    Magnarelli LA; IJdo JW; Ramakrishnan U; Henderson DW; Stafford KC; Fikrig E
    J Wildl Dis; 2004 Apr; 40(2):249-58. PubMed ID: 15362824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ELISA-based measurement of antibody responses and PCR-based detection profiles can distinguish between active infection and early clearance of Borrelia burgdorferi.
    Lazarus JJ; McCarter AL; Neifer-Sadhwani K; Wooten RM
    Clin Dev Immunol; 2012; 2012():138069. PubMed ID: 22110528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy.
    Marangoni A; Sparacino M; Mondardini V; Cavrini F; Storni E; Donati M; Cevenini R; Sambri V
    New Microbiol; 2005 Jan; 28(1):37-43. PubMed ID: 15782625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borrelia burgdorferi sensu lato species in Europe induce diverse immune responses against C6 peptides in infected mice.
    Krupka I; Knauer J; Lorentzen L; O'Connor TP; Saucier J; Straubinger RK
    Clin Vaccine Immunol; 2009 Nov; 16(11):1546-62. PubMed ID: 19726618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease.
    Coleman AS; Pal U
    Clin Vaccine Immunol; 2009 Nov; 16(11):1569-75. PubMed ID: 19776192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi.
    Lawrenz MB; Hardham JM; Owens RT; Nowakowski J; Steere AC; Wormser GP; Norris SJ
    J Clin Microbiol; 1999 Dec; 37(12):3997-4004. PubMed ID: 10565921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enzyme-linked immunosorbent assay, immunofluorescent assay, and recombinant immunoblotting in the serodiagnosis of early Lyme borreliosis.
    Christova I
    Int J Immunopathol Pharmacol; 2003; 16(3):261-8. PubMed ID: 14611730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
    Weiner ZP; Crew RM; Brandt KS; Ullmann AJ; Schriefer ME; Molins CR; Gilmore RD
    Clin Vaccine Immunol; 2015 Nov; 22(11):1176-86. PubMed ID: 26376927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.
    Montgomery RR; Malawista SE; Feen KJ; Bockenstedt LK
    J Exp Med; 1996 Jan; 183(1):261-9. PubMed ID: 8551229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of tests for detection of Borrelia burgdorferi sensu lato infection in patients with diagnosed borreliosis.
    Chmielewska-Badora J; Cisak E; Wójcik-Fatla A; Zwoliński J; Buczek A; Dutkiewicz J
    Ann Agric Environ Med; 2006; 13(2):307-11. PubMed ID: 17196006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal pattern of Borrelia burgdorferi p21 expression in ticks and the mammalian host.
    Das S; Barthold SW; Giles SS; Montgomery RR; Telford SR; Fikrig E
    J Clin Invest; 1997 Mar; 99(5):987-95. PubMed ID: 9062357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay.
    Liang FT; Jacobson RH; Straubinger RK; Grooters A; Philipp MT
    J Clin Microbiol; 2000 Nov; 38(11):4160-6. PubMed ID: 11060084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borrelia burgdorferi spirochetes that harbor only a portion of the lp28-1 plasmid elicit antibody responses detectable with the C6 test for Lyme disease.
    Embers ME; Wormser GP; Schwartz I; Martin DS; Philipp MT
    Clin Vaccine Immunol; 2007 Jan; 14(1):90-3. PubMed ID: 17108288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of OppA2 linear epitopes as serodiagnostic markers for Lyme disease.
    Signorino G; Arnaboldi PM; Petzke MM; Dattwyler RJ
    Clin Vaccine Immunol; 2014 May; 21(5):704-11. PubMed ID: 24623628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.